Literature DB >> 3113537

Deoxyribonucleic acid polymorphism of the apoprotein AI-CIII-AIV gene cluster and coronary heart disease in non-insulin-dependent diabetes.

R C Trembath, D J Thomas, T J Hendra, J S Yudkin, D J Galton.   

Abstract

The prevalence of an uncommon allelic variant (S2) of the apoprotein AI-CIII-AIV gene cluster was determined in non-insulin-dependent diabetics with or without evidence of coronary heart disease and in controls. Frequencies of the S2 allele were 14% for diabetics with coronary heart disease compared with 2% for non-diabetics with no clinical evidence of occlusive vascular disease. No subject with the S2 allele was detected among a further group of matched diabetics without clinical features of macrovascular disease. The results suggest that a genetic component contributes to the susceptibility to coronary heart disease in non-insulin-dependent diabetics. Whether the observed deoxyribonucleic acid variant is aetiological for atherosclerosis or in linkage disequilibrium with other atherogenic loci on chromosome 11 remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3113537      PMCID: PMC1246727          DOI: 10.1136/bmj.294.6587.1577

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  8 in total

1.  Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia.

Authors:  A Rees; J Stocks; C R Sharpe; M A Vella; C C Shoulders; J Katz; N I Jowett; F E Baralle; D J Galton
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

2.  Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors:  L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

3.  Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia.

Authors:  J M Ordovas; E J Schaefer; D Salem; R H Ward; C J Glueck; C Vergani; P W Wilson; S K Karathanasis
Journal:  N Engl J Med       Date:  1986-03-13       Impact factor: 91.245

4.  Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction.

Authors:  G A Ferns; J Stocks; C Ritchie; D J Galton
Journal:  Lancet       Date:  1985-08-10       Impact factor: 79.321

Review 5.  Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease-chicken, egg or neither?

Authors:  R J Jarrett
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

6.  Insulin and apolipoprotein A-1/C-III gene polymorphisms relating to hypertriglyceridaemia and diabetes mellitus.

Authors:  N I Jowett; A Rees; L G Williams; J Stocks; M A Vella; G A Hitman; J Katz; D J Galton
Journal:  Diabetologia       Date:  1984-08       Impact factor: 10.122

7.  Diabetes and cardiovascular risk factors: the Framingham study.

Authors:  W B Kannel; D L McGee
Journal:  Circulation       Date:  1979-01       Impact factor: 29.690

8.  DNA polymorphisms in the apolipoprotein C-III and insulin genes and atherosclerosis.

Authors:  A Rees; J Stocks; L G Williams; J L Caplin; N I Jowett; A J Camm; D J Galton
Journal:  Atherosclerosis       Date:  1985-12       Impact factor: 5.162

  8 in total
  8 in total

1.  Extended haplotypes and linkage disequilibrium between 11 markers at the APOA1-C3-A4 gene cluster on chromosome 11.

Authors:  P Benlian; C Boileau; N Loux; D Pastier; J Masliah; M Coulon; M Nigou; A Ragab; J Guimard; J B Ruidavets
Journal:  Am J Hum Genet       Date:  1991-05       Impact factor: 11.025

Review 2.  DNA polymorphism and the study of disease associations.

Authors:  D N Cooper; J F Clayton
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

3.  Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.

Authors:  L Rigoli; G Raimondo; A Di Benedetto; G Romano; A Porcellini; S Campo; F Corica; G Riccardi; G Squadrito; D Cucinotta
Journal:  Acta Diabetol       Date:  1995-12       Impact factor: 4.280

4.  Electrocardiographic abnormalities and associated factors in Chinese living in Beijing and in Mauritius. The Mauritius Non-Communicable Disease Study Group.

Authors:  N Li; J Tuomilehto; G Dowse; K G Alberti; P Zimmet; Z Min; P Chitson; H Gareeboo; Y Chonghua; D Fareed
Journal:  BMJ       Date:  1992-06-20

5.  Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease--putative association via common antecedents; further evidence from the Whitehall Study.

Authors:  R J Jarrett; M J Shipley
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

6.  Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD.

Authors:  S Chhabra; R Narang; R Lakshmy; S Vasisht; D P Agarwal; L M Srivastava; S C Manchanda; N Das
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

7.  A DNA polymorphism of an apoprotein gene associates with the hypertriglyceridaemia of primary gout.

Authors:  G A Ferns; J Lanham; P Dieppe; D J Galton
Journal:  Hum Genet       Date:  1988-01       Impact factor: 4.132

8.  Extracoronary atherosclerosis and genetic variants of apolipoprotein AI-CIII cluster in myocardial infarction survivors from southern Italy.

Authors:  F De Lorenzo; A Monticelli; S Cocozza; B De Simone; P Rubba
Journal:  Clin Investig       Date:  1994-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.